在生物类似药的市场准入中,现实世界的证据有什么作用?
Steven Simoens1, Catherine M Lockhart2, Delphine F Courmier3
1KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.
Frontiers in pharmacology
|March 11, 2025
概括
现实世界的证据 (RWE) 证实了与参考产品相比,生物类似药的疗效和安全性是可比的. RWE研究解决了生物类药物市场准入的关键问题,包括指示推断和切换影响.
科学领域:
- 药物经济学 药物经济学
- 医疗保健服务研究 医疗服务研究
- 监管科学 监管科学
背景情况:
- 生物仿制药提供了潜在的成本节约,并增加了患者获得生物疗法的机会.
- 尽管获得了监管批准,但关于生物类似药的安全性,疗效和市场整合的剩余不确定性仍然存在.
研究的目的:
- 探索现实世界证据 (RWE) 在解决影响生物类似药物市场准入的关键问题方面的关键作用.
- 展示RWE研究如何成功阐明生物类似药的采用和利用方面.
主要方法:
- 对生物类似药物现有现实世界证据研究的审查.
- 分析RWE对了解生物类似药物的安全性,疗效,适用性推断和切换的贡献.
主要成果:
- 瑞威一贯证实生物仿制药与其参考产品的安全性和有效性概况相似.
- 瑞威已经验证了监管方法,如指示推断和影响生物类似药物的吸收的明智政策.
- 研究说明了生物类似药的好处,并确定了影响其纳入临床实践的操作因素.
结论:
- 现实世界的证据是证明生物类似物互换性和支持市场准入的强大工具.
- RWE有效地解决了超出随机对照试验范围的关键问题,促进了生物类似药的更广泛采用.
相关概念视频
Bioequivalence: Overview
907
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
907
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Drug Control Governance: Regulatory Bodies and Their Impact
134
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
134


